These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23249132)

  • 1. Serotonergic overstimulation in a preterm infant after sertraline intake via breastmilk.
    Müller MJ; Preuß C; Paul T; Streit F; Brandhorst G; Seeliger S
    Breastfeed Med; 2013 Jun; 8(3):327-9. PubMed ID: 23249132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations.
    Stowe ZN; Hostetter AL; Owens MJ; Ritchie JC; Sternberg K; Cohen LS; Nemeroff CB
    J Clin Psychiatry; 2003 Jan; 64(1):73-80. PubMed ID: 12590627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertraline and breastfeeding: review and meta-analysis.
    Pinheiro E; Bogen DL; Hoxha D; Ciolino JD; Wisner KL
    Arch Womens Ment Health; 2015 Apr; 18(2):139-146. PubMed ID: 25589155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient neonatal jitteriness due to maternal use of sertraline (Zoloft).
    Santos RP; Pergolizzi JJ
    J Perinatol; 2004 Jun; 24(6):392-4. PubMed ID: 15167880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
    Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
    Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sertraline and desmethylsertraline in human breast milk and nursing infants.
    Stowe ZN; Owens MJ; Landry JC; Kilts CD; Ely T; Llewellyn A; Nemeroff CB
    Am J Psychiatry; 1997 Sep; 154(9):1255-60. PubMed ID: 9286185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
    El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H
    Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sertraline and N-desmethylsertraline levels in breast-feeding mother-infant pairs.
    Wisner KL; Perel JM; Blumer J
    Am J Psychiatry; 1998 May; 155(5):690-2. PubMed ID: 9585724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phototherapy-mediated syndrome of inappropriate secretion of antidiuretic hormone in an in utero selective serotonin reuptake inhibitor-exposed newborn infant.
    Vanhaesebrouck P; De Bock F; Zecic A; De Praeter C; Smets K; De Coen K; Goossens L
    Pediatrics; 2005 May; 115(5):e508-11. PubMed ID: 15805337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertraline concentrations in pregnant women are steady and the drug transfer to their infants is low.
    Heinonen E; Blennow M; Blomdahl-Wetterholm M; Hovstadius M; Nasiell J; Pohanka A; Gustafsson LL; Wide K
    Eur J Clin Pharmacol; 2021 Sep; 77(9):1323-1331. PubMed ID: 33751155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs.
    Epperson N; Czarkowski KA; Ward-O'Brien D; Weiss E; Gueorguieva R; Jatlow P; Anderson GM
    Am J Psychiatry; 2001 Oct; 158(10):1631-7. PubMed ID: 11578995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.
    Ferreira E; Carceller AM; Agogué C; Martin BZ; St-André M; Francoeur D; Bérard A
    Pediatrics; 2007 Jan; 119(1):52-9. PubMed ID: 17200271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
    J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertraline use during pregnancy and the risk of major malformations.
    Bérard A; Zhao JP; Sheehy O
    Am J Obstet Gynecol; 2015 Jun; 212(6):795.e1-795.e12. PubMed ID: 25637841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of in-utero exposure to selective serotonin reuptake inhibitors and venlafaxine on term and preterm infants.
    Hogue AN; Temple-Cooper ME; Lagzdins M; Worley S; Scwersenski J; Floyd R; Saker F
    J Neonatal Perinatal Med; 2017; 10(4):371-380. PubMed ID: 29286926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The transfer of selective serotonin reuptake inhibitors to human milk].
    Nordeng H; Bergsholm YK; Bøhler E; Spigset O
    Tidsskr Nor Laegeforen; 2001 Jan; 121(2):199-203. PubMed ID: 11475200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose.
    Roca A; Garcia-Esteve L; Imaz ML; Torres A; Hernández S; Botet F; Gelabert E; Subirà S; Plaza A; Valdés M; Martin-Santos R
    J Affect Disord; 2011 Dec; 135(1-3):208-15. PubMed ID: 21890210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toxic hepatitis following sequential treatment with cotrimoxazol, levofloxacin, doxycycline and sertraline in a patient with a respiratory infection].
    García-Aparicio J; Herrero-Herrero JI
    Farm Hosp; 2010; 34(3):152-4. PubMed ID: 20471573
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyponatremia associated with sertraline and fluoxetine: a case report.
    Raphael K; Tokeshi J
    Hawaii Med J; 2002 Mar; 61(3):46-7. PubMed ID: 11965835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin reuptake inhibitors and breastfeeding: a systematic review.
    Orsolini L; Bellantuono C
    Hum Psychopharmacol; 2015 Jan; 30(1):4-20. PubMed ID: 25572308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.